NEW YORK, Nov. 9, 2013 (GLOBE NEWSWIRE) -- The Rosen Law Firm today announced that a class action lawsuit has been filed on behalf of all purchasers of the securities of Unilife Corporation (Nasdaq:UNIS) from July 13, 2011 through September 9, 2013, alleging violations of federal securities law against the Company and certain of its officers and directors.
To join the Unilife class action, go to the website at http://rosenlegal.com or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email firstname.lastname@example.org or email@example.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants issued materially false and misleading statements about Unilife's true business and financial condition in violation of the federal securities laws. Specifically, the complaint alleges that the defendants concealed from investors that: (i) the Company's Unifill syringes failed to comply with the U.S. Food and Drug Administration's ("FDA") validation process; (ii) Unilife's Quality Management System failed to comply with FDA regulations; (iii) Unilife intentionally increased its purchases of Unifill component parts to lead suppliers into believing that Unilife was producing at increased volumes even though its lacked customer demand or manufacturing capacity to support such purchases; and (iv) consequently, the Company's statements were materially false and misleading at all relevant times. As a result, the complaint alleges that when this adverse information was disclosed, it caused the price of Unilife stock to drop, damaging investors.
A class action lawsuit has already been filed on behalf of Unilife investors. If you wish to serve as lead plaintiff, you must move the Court no later than December 31, 2013. If you wish to join the litigation or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at firstname.lastname@example.org or email@example.com.
The Rosen Law Firm focuses on prosecuting securities class action litigation and actions involving financial fraud. The Rosen Law Firm represents investors throughout the globe concentrating its practice in securities class actions.
CONTACT: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm P.A. Tel: (212) 686-1060 Toll Free: 1-866--767-3653 Fax: (212) 202-3827 275 Madison Avenue, 34th Floor New York, New York 10016 firstname.lastname@example.org email@example.com firstname.lastname@example.org www.rosenlegal.comSource: The Rosen Law Firm PA PC